Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $365.82 | $7.21 | 4,973.51% | 7,316.40x | 351.72x | 8.11x | 9.81x | 19.56x | $529.27M | 1.31% | $4.13B | 37.48 | $38.39B | 120.71 | ||
| CORT | CORCEPT THERAPEUTICS INC | $75.54 | $32.38 | 133.29% | 75.54x | 74.24x | 10.55x | 12.57x | 1.05x | $162.57M | 2.08% | $631.90M | 6.10 | $7.83B | 118.63 | ||
| NVO | NOVO NORDISK A S | $48.26 | $150.02 | -67.83% | 13.42x | 2.02x | 4.41x | 8.19x | 0.14x | $9.34B | 4.36% | $26.18B | 5.89 | $225.10B | 9.07 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $449.16 | $28.75 | 1,462.43% | 1,448.90x | 308.51x | 18.39x | 253.71x | 6.17x | $221.36M | 0.37% | $233.89M | 1.78 | $61.06B | 401.93 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.22 | $4.95 | -55.19% | 31.71x | 16.91x | 2.85x | 3.37x | 0.18x | -$11.69M | -6.62% | $52.91M | 0.67 | $173.07M | 19.51 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.88 | $11.21 | -20.75% | 18.50x | 7.24x | 5.89x | 3.75x | 0.39x | -$23.64M | -4.76% | $133.17M | 2.38 | $508.20M | 7.56 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $40.32 | $14.99 | 168.99% | 82.29x | 38.10x | 5.04x | 5.71x | 1.23x | $101.73M | 3.38% | $535.38M | 7.17 | $2.89B | 53.96 | ||
| ARGX | ARGENX SE | $907.98 | $255.77 | 255.00% | 36.28x | 54.26x | 29,289.68x | 7.73x | 3.04x | $467.72M | 0.84% | $7.17B | 117.50 | $53.01B | 65.35 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $200.86 | $60.99 | 229.34% | 86.95x | 28.68x | 15.65x | 4.16x | 1.56x | $30.76M | 0.78% | $950.17M | 48.53 | $4.26B | 41.40 | ||
| GMAB | GENMAB A | $30.26 | $113.62 | -73.37% | 12.92x | 1.75x | 5.45x | 3.38x | 0.11x | $1.19B | 6.15% | $5.75B | 8.96 | $17.81B | 8.90 | ||
| VCEL | VERICEL CORP | $39.86 | $7.22 | 452.15% | 153.31x | 177.63x | 7.78x | 6.26x | 2.58x | $20.38M | 1.01% | $321.86M | 6.38 | $2.01B | 68.69 | ||
| KRYS | KRYSTAL BIOTECH INC | $206.16 | $83.37 | 147.28% | 29.88x | 40.47x | 16.00x | 5.25x | 1.76x | $166.02M | 2.78% | $1.14B | 39.30 | $5.60B | 28.95 | ||
| TECH | BIO-TECHNE CORP | $59.38 | $16.13 | 268.11% | 118.76x | 29.06x | 7.59x | 4.71x | 1.66x | $224.06M | 2.43% | $1.97B | 12.65 | $9.50B | 43.01 | ||
| RPRX | ROYALTY PHARMA PLC | $39.16 | $41.36 | -5.31% | 22.25x | 8.55x | 7.20x | 2.35x | 0.47x | $2.11B | 12.48% | $9.62B | 22.28 | $30.61B | 29.32 | ||
| CRMD | CORMEDIX INC | $11.24 | $16.49 | -31.85% | 4.95x | 5.30x | 3.98x | 2.37x | 1.25x | $74.42M | 8.72% | $374.13M | 4.93 | $986.02M | 8.78 | ||
| HALO | HALOZYME THERAPEUTICS INC | $70.03 | $76.31 | -8.23% | 14.32x | 11.15x | 6.60x | 16.34x | 0.54x | $602.40M | 7.34% | $503.92M | 4.30 | $9.33B | 11.03 | ||
| MDXG | MIMEDX GROUP INC | $7.38 | $3.59 | 105.76% | 26.36x | 17.02x | 2.78x | 4.57x | 1.39x | $66.82M | 6.11% | $238.95M | 1.61 | $969.12M | 14.00 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.99 | $0.85 | 843.03% | 114.14x | 75.81x | 6.77x | 7.55x | 6.70x | $3.05M | 0.43% | $101.92M | 1.12 | $730.46M | 55.22 | ||
| VCYT | VERACYTE INC | $39.35 | $8.83 | 345.71% | 100.90x | 98.50x | 6.26x | 2.47x | 2.22x | $98.21M | 3.17% | $1.26B | 15.98 | $2.83B | 49.72 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.73 | $41.63 | 31.47% | 20.12x | 18.02x | 3.40x | 1.74x | 0.78x | $832.13M | 7.92% | $6.06B | 31.54 | $9.86B | 12.76 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $437.15 | $171.63 | 154.70% | 30.55x | 23.78x | 9.53x | 6.40x | 1.83x | $3.34B | 2.99% | $17.32B | 67.76 | $107.81B | 23.12 | ||
| INCY | INCYTE CORP | $104.15 | $66.46 | 56.70% | 17.24x | 14.95x | 4.23x | 4.40x | 1.23x | $1.20B | 5.87% | $4.65B | 23.77 | $18.03B | 10.71 | ||
| ADMA | ADMA BIOLOGICS INC | $15.56 | $9.22 | 68.68% | 17.68x | 25.71x | 7.60x | 8.59x | 1.40x | $40.73M | 1.10% | $431.19M | 1.81 | $3.72B | 21.59 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.03 | $39.37 | -13.56% | 10.54x | 10.42x | 2.37x | 2.35x | 0.61x | $296.89M | 15.16% | $835.12M | 14.51 | $1.48B | 5.49 | ||
| INVA | INNOVIVA INC | $22.25 | $18.06 | 23.19% | 11.77x | 18.70x | 3.95x | 1.65x | 1.16x | $196.54M | 12.79% | $1.01B | 14.63 | $1.44B | 6.73 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.35 | $7.08 | 116.70% | 26.47x | 23.21x | 7.61x | 5.53x | 1.53x | $119.87M | 5.92% | $365.77M | 2.78 | $2.03B | 19.60 | ||
| EXEL | EXELIXIS INC | $41.65 | $27.05 | 53.97% | 16.93x | 17.38x | 4.89x | 5.17x | 1.21x | $779.77M | 6.97% | $2.16B | 8.05 | $10.97B | 11.82 | ||
| MNKD | MANNKIND CORP | $5.06 | $1.27 | 299.25% | 50.60x | 53.43x | 4.95x | -34.88x | 2.72x | $43.39M | 2.79% | -$44.55M | -0.15 | $1.79B | 24.41 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $693.50 | $347.18 | 99.75% | 15.96x | 16.22x | 5.04x | 2.35x | 2.70x | $4.22B | 5.88% | $30.96B | 298.82 | $73.09B | 12.79 | ||
| UTHR | UNITED THERAPEUTICS CORP | $466.40 | $192.51 | 142.27% | 16.38x | 16.61x | 6.53x | 3.05x | 6.33x | $1.12B | 5.49% | $6.59B | 150.46 | $18.74B | 10.57 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.18 | $10.78 | 115.06% | 12.95x | 15.59x | 4.92x | 3.10x | 21.86x | $234.54M | 8.25% | $920.25M | 7.51 | $2.16B | 6.67 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.